NRF2-activation in DC protects from Th1/Th17-mediated autoimmune disease

被引：0
|
作者：
Brueck, J. [1 ]
Geisel, J. [1 ]
Glocova, I. [1 ]
Dengler, K. [1 ]
Roecken, M. [1 ]
Ghoreschi, K. [1 ]
机构：
[1] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2014年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E38 / E38
页数：1
相关论文
共 50 条
  • [1] Low zone tolerance protects from Th1/Th17-mediated colitis
    Schmidt, T.
    Lorenz, N.
    Raker, V.
    Reissig, S.
    Waisman, A.
    Weigmann, B.
    Steinbrink, K.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E2 - E2
  • [2] Curcumin protects from autoimmune disease by modulating DC and inhibiting Th1/Th17 responses
    Brueck, J.
    Glocova, I.
    Ghashghaeinia, M.
    Roecken, M.
    Ghoreschi, K.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 191 - 191
  • [3] Curcumin protects from autoimmune disease by modulating DC differentiation and suppressing Th1 and Th17 cells
    Geisel, J.
    Glocova, I.
    Brueck, J.
    Dengler, K.
    Roecken, M.
    Ghoreschi, K.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 181 - 181
  • [4] Curcumin protects from inflammatory autoimmune disease by inducing immuno suppressive DC and inhibiting Th1/Th17 responses
    Brueck, Juergen
    Glocova, Ivana
    Roecken, Martin
    Ghoreschi, Kamran
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S11 - S11
  • [5] T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease
    O'Connor, Richard A.
    Cambrook, Helen
    Huettner, Katja
    Anderton, Stephen M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (11) : 2818 - 2823
  • [6] GH2-34, a novel compound, inhibits Th17 cells and protects against Th17-mediated autoimmune diseases
    Tang, X.
    Wang, C.
    Li, Z.
    Yin, Z.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1935 - 1935
  • [7] Astrocyte Phenotypes in Th1-Versus Th17-Mediated Experimental Autoimmune Encephalomyelitis
    Monteagudo, Alina
    Passino, Ryan
    Giger, Roman
    Segal, Benjamin M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 137 - 137
  • [8] Th1/Th17-mediated colitis is diminished after epicutaneous and oral tolerance induction
    Schmidt, T.
    Lorenz, N.
    Raker, V. K.
    Reissig, S.
    Waisman, A.
    Weigmann, B.
    Steinbrink, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S15 - S15
  • [9] TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
    Pappu, Bhanu P.
    Borodovsky, Anna
    Zheng, Timothy S.
    Yang, Xuexian
    Wu, Ping
    Dong, Xingwen
    Weng, Shawn
    Browning, Beth
    Scott, Martin L.
    Ma, Li
    Su, Lihe
    Tian, Qiang
    Schneider, Pascal
    Flavell, Richard A.
    Dong, Chen
    Burkly, Linda C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (05): : 1049 - 1062
  • [10] Proteoglycan induced arthritis is a Th1-not Th17-mediated disease.
    Doodes, Paul D.
    Cao, Yanxia
    Tunyogi-Csapo, Miklos
    Finnegan, Alison
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S810 - S811
12345